CompletedPhase 4NCT04158752

Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia

Studying Trigeminal neuralgia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Sweta Sengupta, MD, MD
Duke University
Intervention
Galcanezumab(drug)
Enrollment
26 enrolled
Eligibility
18-80 years · All sexes
Timeline
20202023

Study locations (1)

Collaborators

Eli Lilly and Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04158752 on ClinicalTrials.gov

Other trials for Trigeminal neuralgia

Additional recruiting or active studies for the same condition.

See all trials for Trigeminal neuralgia

← Back to all trials